Effects of zinc on bovine mammary epithelia by Shaffer, James
  
EFFECTS OF ZINC ON BOVINE MAMMARY EPITHELIA 
 
 
by 
 
 
JAMES SHAFFER 
 
 
B.S., Peru State College, 2014 
 
 
A THESIS 
 
 
submitted in partial fulfillment of the requirements for the degree 
 
 
MASTER OF SCIENCE 
 
 
Department of Animal Sciences & Industry 
College of Agriculture 
 
 
 
KANSAS STATE UNIVERSITY 
Manhattan, Kansas 
 
 
2016 
 
 
 
 
 
Approved by: 
 
Major Professor 
Dr. Barry Bradford 
  
  
Copyright 
JAMES SHAFFER 
2016 
  
  
Abstract 
Two experiments were conducted to explore potential cellular and biochemical 
mechanisms by which zinc may impact milk production and mammary health of dairy cattle. For 
the first experiment, twelve lactating Holstein cows were enrolled in a replicated 3 × 3 Latin 
square, and provided a balanced diet supplemented with either 30 ppm zinc as ZnSO4 (30-ZS), 
60 ppm zinc as ZnSO4 (60-ZS), or 60 ppm zinc as a mixture of ZnSO4 and Zn methionine (60-
ZM). Blood and milk were collected and analyzed for markers of blood-milk leak and dairy food 
properties of milk. Milk cells were also isolated and analyzed for RNA abundance of genes 
related to zinc-mediated apoptosis. Aside from a tendency for 60-ZS to increase feed intake and 
60-ZM to increase milk fat compared to 30-ZS, no effects were observed on performance, 
markers of blood-milk leak, transcript abundance of selected genes, or dairy food properties of 
milk. A cell culture study was also conducted using immortalized bovine mammary epithelial 
(MAC-T) cells. Messenger RNA abundance of GPR39—a G protein-coupled receptor shown to 
regulate cellular activity in response to extracellular zinc concentrations in other epithelial cell 
lines—was knocked down using RNA interference. Following GPR39 knockdown, cells were 
treated with 0 or 100 µM zinc. Phosphorylation of the kinases ERK1/2 and AKT was measured 
in GPR39-knockdown and control cells treated with either 0 or 100 µM zinc. No effect of zinc 
treatment or GPR39 knockdown was detected on kinase phosphorylation. Interestingly, the 100 
µM zinc treatment showed a tendency to increase GPR39 mRNA abundance in control cells. 
There remain many questions about the cellular mechanisms whereby zinc can impact milk 
production in dairy cattle.  
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Chapter 1 - Literature Review: Zinc Nutrition in the Dairy Cow 
 Introduction 
The soft, gray element which occupies the topmost position of the Group 12 transition 
metals may not possess great inherent value. As the 27th-most abundant element in Earth’s crust 
(Vallee and Falchuk, 1993), it is not particularly rare. In industry, it is extensively used as a 
galvanizing material to protect other metals from rust. However, removal of this common 
material from the diet of any higher animal quickly demonstrates its paramount importance as a 
micronutrient. 
Many properties of zinc lend themselves toward important and unique biochemical 
functions. As a Group 12 transition metal with a filled D orbital, zinc has virtually no redox 
activity in biological systems. As a divalent cation, it possesses a high affinity for specific amino 
acids—in particular, cysteine, histidine, aspartate, and glutamate. Furthermore, it is highly stable 
in a wide variety of binding geometries, and easily accepts electron pairs, making it an excellent 
Lewis acid. Likely because of these properties, zinc is a known component of hundreds of 
enzymes—by some estimates, over 10% of the human proteome (Andreini et al., 2006). 
Knowing this, it is no surprise that the biological functions of zinc are numerous and variable, 
that deficiency of this element can lead to a number of complications, and that supplementation 
can lead to a number of benefits. 
The importance of zinc in nutrition has been known since the early 1930’s, when its 
essentiality was described in rats (Todd et al., 1934). For some twenty-odd years following this 
discovery, it was widely believed that, while deficiencies could be demonstrated in the 
laboratory, they simply did not occur in practice. It wasn’t until 1955 that a practical example of 
zinc deficiency was described in farm animals, and zinc supplementation was recognized as a 
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potent treatment for parakeratosis in swine (Tucker and Salmon, 1955). Soon after, zinc 
deficiency was also noted in human populations (Halsted et al., 1972) and cattle (Legg and Sears, 
1960).  
Since then, study of this micronutrient has greatly expanded knowledge of the many ways 
in which zinc interacts with biological systems. Deficiency leads to gastrointestinal upset, skin 
disorders, immune suppression, delayed wound healing, growth retardation, and inhibited 
reproductive development if left uncorrected for a long enough time (reviewed in Machen et al., 
1996; Vallee and Falchuk, 1993). Zinc supplementation has been shown to improve performance 
of beef (Greene et al., 1988) and dairy cattle (Nayeri et al., 2014). Especially impactful for dairy 
cattle, dietary zinc levels have been shown to impact mammary health (Nayeri et al., 2014). 
While no definitive explanation has been presented for zinc effects on mammary health in cattle, 
basic research in mouse models have uncovered a variety of mechanisms in mammary epithelial 
cells (Hennigar et al., 2015; Dempsey et al., 2012). 
  
 Zinc Requirements and Homeostasis 
 Requirements for the dairy cow 
In the NRC model (2001), recommendations for dietary zinc in dairy cattle are 
determined by a factorial approach. Considerations are made for endogenous fecal and urinary 
losses, gestation, lactation, and growth, where they apply. The sum of these requirements is 
considered to be the total requirement for absorbed zinc. Dairy cattle absorb zinc with an 
efficiency of about 15% (Miller and Cragle, 1965), so the absorbed requirement is divided by 
0.15 to determine the dietary requirement. Using this model, the dietary recommendation for a 
lactating cow (650 kg, producing 40 kg milk/d) is about 63 mg Zn/kg dry matter intake (DMI). 
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By comparison, a pregnant nonlactating cow (270 d gestation) would require much lower dietary 
levels (23 mg/kg), despite also having a lower predicted DMI. Even a growing heifer (300 kg, 
0.7 kg average daily gain) requires lower dietary levels of zinc (33 mg/kg). These predictions 
illustrate the relatively high impact of lactation on zinc requirements, even in comparison to 
growth or gestation, making the management of this essential element particularly important in 
dairy cattle. Cope et al. (2009) have shown that provision of a moderately zinc-deficient diet (~ 
40 mg Zn/kg diet DM) to early lactation Holstein cows, as determined by the NRC (2001) 
model, results in increased milk somatic cell counts and amyloid A concentrations compared to a 
zinc-sufficient diet (~60 mg Zn/kg diet dry matter). In this study, milk and component yield was 
not affected by level of supplemental zinc. These results suggest that feeding dietary zinc levels 
below NRC recommendations can be done without directly impacting milk production; however, 
mammary health is likely to be compromised. 
Research has also been conducted into supplementing above the NRC recommendations, 
with limited effects on animal performance or health. In a study by Kincaid et al. (1997), 
growing heifers receiving a base diet containing 60 ppm zinc were compared to heifers on the 
same diet plus 150 ppm supplemental zinc provided as a zinc-amino acid chelate (zinc 
methionine/lysine), 300 ppm zinc as zinc methionine/lysine, or 300 ppm zinc as zinc oxide. In 
this study, no effects were observed on either immune function or performance of the calves; the 
only observed result was a higher bioavailability of the amino acid-chelated zinc as judged by 
increases in tissue zinc concentrations.  
A 1998 study by Campbell and Miller reported that provision of 800 mg supplemental 
zinc to dry cows receiving ~ 1100 mg zinc/d from their base diet reduced days to first observed 
estrus following calving, but did not affect other health or performance measures. In the context 
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of this study, zinc was tested as a potential antioxidant to ameliorate negative effects of oxidative 
stress in the periparturient cow. Interestingly, supplementing with iron, a prooxidant, also 
reduced days to first estrus as well as days open. In the words of the authors, “it cannot be 
concluded with certainty that reproductive efficiency was improved by prepartum 
supplementation with vitamin E or Zn without also acknowledging it was improved by excess 
Fe.”  
Responses have been demonstrated in dairy cattle when comparing zinc sources. Amino 
acid-chelated zinc has been shown to be more bioavailable than other inorganic forms of zinc in 
chickens (Wedekind et al., 1992), catfish (Paripatananont and Lovell, 1995), lambs, and heifers 
(Spears, 1989; Kincaid et al., 1997). Nayeri et al. (2014) have further shown that increasing the 
proportion of supplemental zinc supplied as zinc methionine can increase milk production, 
reduce services/conception, and improve feed efficiency in Holstein cows receiving a diet 
containing 111 – 149 ppm zinc. Further, multiparous cows receiving zinc methionine had 
reduced somatic cell counts in milk and increased concentration of IgG in colostrum. While 
some question remains about the effect of the organic constituent (e.g. methionine in zinc 
methionine) in these supplements, their benefit compared to inorganic forms of zinc have been 
demonstrated. 
 Absorption 
Zinc absorption is controlled by a dynamic, multifactor system in cattle. At various sites 
along the gastrointestinal tract, zinc can be either absorbed from digesta as a nutrient or secreted 
as a component of endogenous digestive factors. The efficiency at which dietary zinc is absorbed 
and retained is impacted by a number of known factors including animal age, feeding rate, zinc 
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content of the diet, and zinc status of the animal. Mechanisms for absorption of zinc occur in 
three general stages: cellular uptake, transcellular transport, and transport into the bloodstream.  
Zinc is absorbed primarily in the small intestine, though the location of highest 
absorption may vary across species (Naveh et al., 1988; Lee et al., 1989). In general, zinc 
secretion is highest in the duodenum, and absorption of dietary and endogenous zinc occurs 
along the remaining length of small intestine. In cattle, appreciable uptake also occurs in the 
abomasum (Miller and Cragle, 1965). In addition, some zinc secretion occurs at or prior to the 
rumenoreticulum (Hiers Jr et al., 1968), possibly as a component of saliva.  
Miller et al. (1969) have shown that both zinc-deficient animals and animals fed zinc-
deficient diets absorb and retain a larger percentage of dietary zinc. Observations have also 
shown absorption rates (amount absorbed/total intake) to be higher in calves compared to adult 
cows (Miller and Cragle, 1965). In a study by Miller et al. (1968), young calves (2.5 mo) 
retained a higher proportion of dietary zinc than older calves (4.5 mo) when fed a zinc-sufficient 
diet; however, age did not affect zinc retention rates when a zinc-deficient diet was fed. Growing 
calves fed at maintenance have also been shown to retain a lower proportion of dietary zinc than 
calves receiving the same diet at amounts calculated to support normal growth (Miller, 1969). It 
is likely, then, that observed differences in zinc retention (and, possibly, absorption) at different 
ages may be a reflection of different growth rates and rates of tissue deposition. 
The cellular mechanisms by which zinc is absorbed from the diet are not yet completely 
elucidated. It has been known for a long time that zinc uptake in the small intestine occurs by 
both saturable and unsaturable processes, or that zinc both passively diffuses and is actively 
transported across the apical membrane of intestinal epithelial cells (Steel and Cousins, 1985; 
Krebs, 2000). The main zinc transporter on the apical membrane of enterocytes is a zinc import 
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protein encoded by the ZIP4 gene (Wang and Zhou, 2010). Mutations in this gene are 
responsible for the genetic disorder known as acrodermatitis enteropathica in humans (Wang et 
al., 2002; Küry et al., 2002) and for bovine hereditary zinc disorder (BHZD or lethal trait A46) in 
cattle (Yuzbasiyan-Gurkan and Bartlett, 2006). Both of these disorders are characterized by skin 
disorders and diarrhea, among other signs, and are effectively treated with supplemental zinc in 
the diet, consistent with the idea of a redundant unsaturable pathway for zinc uptake. On the 
basolateral side of enterocytes, another zinc transporter, ZnT1, transports zinc into the 
bloodstream (Wang and Zhou, 2010). 
Inside the enterocyte, almost all zinc is bound by proteins, nucleic acids, and various 
small organic molecules (Eide, 2006), leaving very little free ionized zinc. Transport of zinc 
across the enterocyte is generally believed to be the product of the interactions of two proteins—
CRIP and metallothionein—described quite thoroughly in rodents. Both CRIP (Birkenmeier and 
Gordon, 1986; Hempe and Cousins, 1991) and metallothionein (Kägi and Schäffer, 1988) bind to 
zinc and are highly expressed in intestinal tissue. As described by Hempe and Cousins (1991, 
1992) in rats, CRIP appears to be responsible for transport of zinc across the cell, while 
metallothionein binds to and sequesters zinc within the cell, until the cell is sloughed and passed 
in the feces. While some early research suggested a direct relationship between metallothionein 
levels and absorption rate of zinc (Starcher et al., 1980), other studies have since shown that 
increased intestinal metallothionein leads to decreased absorption of zinc. Davis et al. (1998) 
found that metallothionein-knockout mice had higher serum zinc levels, while metallothionein-
transgenic (overexpressing) mice had lower serum zinc than control mice following an oral zinc 
dose. By conducting the experiment in transgenic animals, they were able to attribute the 
observed decrease in serum zinc directly to the increased metallothionein expression, an 
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observation consistent with previous research correlating increases in metallothionein with 
decreases in zinc absorption (Hoadley et al., 1988; Hempe and Cousins, 1992). In addition, 
metallothionein expression in many tissues, including intestinal tissue, is induced by zinc 
exposure (Kägi and Schäffer, 1988), supplying a plausible mechanism by which zinc absorption 
rates may be regulated by dietary zinc intake. In line with this, Hempe and Cousins (1992) found 
that rats fed a low zinc diet had lower levels of intestinal metallothionein than high-zinc rats. 
Low-zinc rats also were found to have higher fractional zinc absorption rates, a lower proportion 
of a 65Zn dose bound to metallothionein, and a higher proportion of 65Zn bound to CRIP. Further, 
as luminal zinc levels increased from 5 to 300 µM, the percentage of 65Zn bound to CRIP 
dropped from 42% to 25% while the moles of 65Zn bound to CRIP remained the same, in line 
with previous predictions of saturable transport kinetics (Steel and Cousins, 1985). 
 Distribution 
Zinc is ubiquitous in the tissues of ruminants, with generally higher concentrations in 
muscle and bone. Once absorbed, zinc appears in tissues at variable rates. Metabolically active 
tissues have very rapid turnover of zinc. In blood plasma and liver, absorbed zinc accumulates 
very quickly (peaking in 1-3 days), but is retained for a relatively short period (declining rapidly 
over 3-4 weeks; Miller, 1969). In contrast, bone, hair, muscle, and erythrocytes have a very low 
turnover, and accumulate dietary zinc over the course of several weeks. 
As stated above, the vast majority of intracellular zinc is bound to proteins and various 
organic molecules. This holds true also in blood serum (Faure et al., 1990). Serum zinc is mostly 
protein-bound; in humans, the majority of serum zinc has been shown to be bound to albumin 
and alpha-2-macroblobulin (Foote and Delves, 1984). In portal circulation of rats, a large amount 
of zinc is also bound to a protein called transferrin (Evans and Winter, 1975). Plasma zinc 
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concentrations in cattle fall normally in the range of 0.8 – 1.2 ppm, and drop rapidly in the case 
of deficiency (Mills et al., 1967). While most tissue zinc concentrations do not change 
appreciably during zinc deficiency, repeated measures below 0.4 ppm of plasma zinc are strong 
enough indicators of a deficiency to be used diagnostically in cattle (Miller, 1970).  
Cow’s milk typically contains ~ 4 ppm zinc (Miller, 1970), over 95% of which is 
associated with casein micelles (Blakeborough et al., 1983). When lactating cows are fed high 
dietary levels of zinc, zinc levels of milk also rise, though to a lesser degree than plasma zinc 
(Miller et al., 1965a), suggesting that zinc secretion into milk is regulated within the mammary 
gland. While knowledge of mammary epithelial cell zinc regulation in the bovine is limited, it 
has been studied extensively in mice and mouse cell lines (reviewed in McCormick et al., 2014). 
Pathway analysis combined with cell localization studies indicate that ZIP5, ZIP8, and ZIP10 are 
likely involved in zinc import to mouse mammary epithelial cells during lactation (Kelleher et 
al., 2012). On the luminal membrane, ZnT2 and ZnT4 have both been shown to transport zinc 
from mammary epithelial cells into milk (Michalczyk et al., 2002; Chowanadisai et al., 2006). In 
addition, a mutation in ZnT4 causes the “lethal milk” phenotype in mice, a disorder leading to 
low zinc concentrations in milk which causes zinc deficiency and death in nursing pups (Piletz 
and Ganschow, 1978; Huang and Gitschier, 1997). Zinc can also be resorbed into the cell from 
the alveolar lumen. Kelleher et al. (2009) have shown that the zinc import protein, ZIP3, 
functions in this manner. Other ZIP proteins also likely function in this way (Kelleher et al., 
2012), based on cell localization and expression. 
Feces is the main route of zinc excretion. In mature cows, 86% of a daily dose of 65Zn 
was observed in the feces, while less than 0.2% was observed in the urine (Miller and Cragle, 
1965). Alimentary secretions of zinc in cattle are impacted by the both the zinc level of the diet 
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and the zinc deficiency status of the animal. Fecal endogenous zinc decreases for both deficient 
diets and deficient animals (Miller, 1969). 
Dietary factors 
A number of factors can impact the availability of zinc in a diet. Determining those 
factors, the degree of their impact, and potential interactions between factors has been the subject 
of much research to date. To illustrate this, studies have been performed determining the zinc 
requirements of ruminants fed semi-purified diets (Mills et al., 1967). In such diets, zinc 
requirements for growing calves are very low, 8 – 12 ppm. In contrast, growing calves on late-
maturity pastures have been documented to show signs of severe zinc deficiency on diets 
providing at least 20 ppm Zn (Legg and Sears, 1960; Mayland et al., 1980). This disparity shows 
that dietary factors exist that drastically impact the efficiency with which cattle utilize dietary 
zinc. 
Cadmium and lead both interfere with zinc absorption (Powell et al., 1967; NRC, 2001). 
In humans, supplemental iron has also been shown to interfere with zinc absorption. Sandstrom 
et al. (1985) showed that iron supplements, when taken on an empty stomach, interfered with 
zinc absorption. The inclusion of histidine or the consumption of a meal along with the 
supplement reversed this effect. While ruminants are not likely to consume large amounts of iron 
on an empty stomach, this does provide an interesting observation of improved zinc 
bioavailability with inclusion of a zinc ligand. In very large amounts, copper can also interfere 
with zinc absorption, though this is unlikely in cattle, and typically it is excess zinc which 
interferes with copper absorption (NRC, 2001). In monogastrics, high levels of calcium can also 
negatively impact zinc absorption (Wood and Zheng, 1997), especially in conjunction with high 
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levels of dietary phytate (Oberleas et al., 1960), though this effect also has not been observed in 
ruminants. 
Several organic molecules also influence the availability of zinc in the diet. Perhaps the 
most prominent of these is phytate. In monogastrics, phytate inhibits zinc absorption by binding 
zinc and preventing its absorption in the intestine (Lonnerdal, 2000). This effect can be observed 
in preweaned calves receiving soybean protein in milk replacer (Miller, 1967); however, in 
mature ruminants, most phytate is digested by rumen microbes before it reaches the small 
intestine, preventing its interference with zinc absorption (NRC, 2001). Small molecules acting 
as chelating agents may also enhance zinc uptake, by keeping zinc in solution and allowing it 
access to the brush border membrane. For instance, inclusion of EDTA in the diet of turkey 
poults was shown to ameliorate the negative effects of phytate on zinc absorption (Kratzer et al., 
1959). However, these chelating agents can also interfere with transport of zinc into the blood 
once it is absorbed (Hill et al., 1987; Hempe and Cousins, 1989). Some amino acids, when 
complexed with zinc, will also improve zinc bioavailability. Histidine (Schölmerich et al., 1987; 
Sandström et al., 1985) and methionine (Wedekind et al., 1992) have been shown to improve 
bioavailability of zinc. In lambs fed a semi-purified diet, zinc methionine had the same 
absorption rate as zinc oxide, but a higher retention rate (Spears, 1989). Replacing inorganic 
forms of zinc with zinc methionine can lead to improvements in carcass quality of finishing 
steers (Greene et al., 1988), and milk production and mammary health of lactating cows (Nayeri 
et al., 2014). These production and health benefits are well established; however, the specific 
cellular and molecular mechanisms responsible remain to be determined. 
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 Biological Impacts 
Zinc plays important roles in integumentary, immune, neurological, and reproductive 
systems. Deficiency is characterized by skin lesions, diarrhea, inhibited immune function, and 
growth retardation (Chai et al., 1999; Yuzbasiyan-Gurkan and Bartlett, 2006). Its importance in 
the diet of animals has been known at least since the 1930’s, when it was shown to be necessary 
for the growth of rats (Todd et al., 1934). Deficiencies were not described in humans until the 
1960’s when “nutritional dwarfism” was linked to zinc-poor, phytate-rich diets of the Middle-
Eastern lower class (Halsted et al., 1972). About the same time, zinc deficiency was described in 
cattle grazing late-maturity pastures (Legg and Sears, 1960). Since then, this element has been 
shown to impact a number of cellular pathways in a variety of tissue types. 
Concentrations of intracellular zinc range from 0.1 – 0.5 mM in both prokaryotic and 
eukaryotic cells (Eide, 2006). The vast majority of this intracellular zinc is bound to proteins, 
nucleic acids, lipids, and a variety of small organic molecules. Direct measurement of unbound 
“free” zinc in the cell is difficult; however, binding affinities of many zinc-containing 
metalloproteins are in the nanomolar to picomolar range. If intracellular free zinc is in this range, 
it composes at most 0.001% of total intracellular zinc, suggesting tight regulation within the cell. 
 Zinc and the proteome 
Recent estimates predict that approximately 10% of the human proteome is made up of 
zinc-binding proteins (Andreini et al., 2006) belonging to all classes of enzymes (Vallee and 
Falchuk, 1993), in which zinc provides both structural and functional benefits. 
These zinc metalloproteins can be categorized based on their function and binding 
geometry (reviewed in McCall et al., 2000). When only one zinc is bound per active site, the zinc 
atom is said to be catalytic. Multiple zinc atoms bound to a single active site are considered co-
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catalytic. Finally, when a single zinc atom is bound to a motif and simply stabilizes the protein’s 
tertiary structure, it is said to be a structural zinc atom. For example, matrix metalloproteases 
(Eide, 2006), a class of enzymes which are involved in remodeling of extracellular matrix, tissue 
growth, and angiogenesis, require a catalytic zinc to function. Other metalloenzymes in which 
zinc performs a catalytic role include carbonic anhydrase and carboxypeptidase, whereas zinc 
has a co-catalytic role in alkaline phosphatase and phospholipase C (Holt et al., 2012). Protein 
kinase C is an example of a metalloenzyme containing a structural zinc ion. Alcohol 
dehydrogenase is a unique zinc metalloenzyme in that it is the only known enzyme to contain 
both a catalytic and a structural zinc (Vallee and Falchuk, 1993). 
One highly important and biologically influential group of zinc-binding proteins are the 
transcription factors, many of which contain a number of “zinc finger” motifs. These zinc fingers 
allow the transcription factors to recognize and bind to response elements in DNA to promote or 
inhibit expression of specific genes. One such transcription factor, MTF-1 actually responds to 
extracellular zinc concentrations to regulate expression of genes related to zinc homeostasis 
within cells (Andrews, 2001). Other examples of zinc-containing transcription factors include 
steroid and retinoid receptors (Hardin et al., 2012), and factors which influence cellular 
autophagy (Li et al., 2015) and tissue development (Sum et al., 2005).  
The metallothioneins are a group of metalloproteins which bind metal ions in a fashion 
which defies the classification scheme described above. At 61-62 amino acids, these small 
proteins are named for their high sulfur and metal composition. A highly-conserved sequence of 
20 cysteine residues is present in all mammalian metallothioneins, which binds strongly to zinc 
and other heavy metals at a ratio of 7 mol metal/mol protein (Vallee and Falchuk, 1993). Unlike 
any other known metalloproteins, metallothioneins bind metal ions in clusters with a unique 
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binding geometry unlike the stereotypical catalytic, co-catalytic, or structural geometries. 
Regulation of metallothionein is thought to be a mechanism by which cells can regulate the 
intracellular concentrations of unbound zinc and other metals (Kägi and Schäffer, 1988).  
 Zinc transport 
Zinc transport in mammalian cells is mediated nearly entirely by transporters from two 
families: ZIP (SLC39) and ZnT (SLC30). Transporters belonging to these families are believed 
to be largely responsible for maintaining zinc levels within the cell and intracellular 
compartments. The two groups have opposite functions—ZIP transporters move zinc into the 
cytosol of cells, either from the extracellular matrix or from intracellular compartments; ZnT 
transporters transfer zinc out of the cytosol, into the extracellular matrix or intracellular 
compartments. Members of both groups can be found in all taxonomic kingdoms (Gaither and 
Eide, 2001), and in all tissue types in mammals (Lichten and Cousins, 2009; Eide, 2006). ZIP 
transporters typically have 8 transmembrane domains with N- and C-termini located on the 
extracytosolic side of a membrane. ZnT transporters have 6 transmembrane domains, with both 
termini on the cytosolic side of a membrane. Both contain a histidine-rich loop between 
transmembrane domains 3 and 4, which is thought to be a zinc-binding site. There are 14 known 
members of the SLC39 (ZIP) family found in mammals, and 10 of the SLC30 (ZnT) family 
(Lichten and Cousins, 2009). 
Transporters from both families are known to perform essential functions in a variety of 
cell types. The first zinc transporter described in mammals was ZnT1 (Palmiter and Findley, 
1995). As discussed above, ZnT1 transports zinc from enterocytes into the blood (Wang and 
Zhou, 2010), and may perform a similar function in kidney cells (Lichten and Cousins, 2009). 
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The ZIP1 protein is constitutively expressed in all tissues of mice and humans (Eide, 
2006). It is located in the plasma membrane of zinc-deficient cells and the intracellular 
compartments of zinc-replete cells. As discussed above, ZIP4 is an important protein for dietary 
zinc uptake. Mutations in the ZIP4 gene lead to zinc deficiency disorders in humans (Wang et 
al., 2002) and cattle (Yuzbasiyan-Gurkan and Bartlett, 2006). Other ZIP proteins are involved in 
cellular zinc uptake in other tissues such as liver (Liuzzi et al., 2005), and mammary epithelium 
(Kelleher and Lönnerdal, 2005). 
 Apoptosis 
The importance of dietary zinc can be inferred from the frequent observations of zinc-
containing enzymes, and from the impacts of zinc deficiency in vivo. Closer analyses of a more 
basic nature also reveal a number of cellular pathways which are directly affected by zinc 
availability. For example, zinc availability has been shown to affect apoptosis rates in a variety 
of tissues—the trachea (Truong-Tran et al., 2003), intestine (Cohen et al., 2012), mammary 
gland (Hennigar et al., 2015; Dempsey et al., 2012; Seo et al., 2011), skin, thymus, testes, retina, 
and pancreas (Truong-Tran et al., 2001), to name a few. 
The exact mechanism by which zinc impacts apoptosis varies in these tissues. In the case 
of airway epithelial cells, zinc protects cells from oxidative damage, and prevents activation of 
the pro-apoptotic protein, caspase (Truong-Tran et al., 2003). In vitro, intestinal epithelial cells 
are protected from butyrate-induced apoptosis by a zinc-dependent upregulation of the anti-
apoptotic protein, clusterin (Cohen et al., 2012). Mammary epithelial cells undergo two forms of 
cell death during involution: the first a lysosomal-mediated cell death occurring during an early 
reversible stage of involution, the second being via the intrinsic mitochondrial-mediated 
apoptotic pathway which occurs during a later irreversible stage of involution (McCormick et al., 
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2014). Zinc availability has been shown to impact lysosomal-mediated cell death (Hennigar et 
al., 2015), and may also play a role in apoptosis via the intrinsic pathway (Seo et al., 2011) in 
mammary epithelial cells. 
 Immune effects 
Many nutritional deficiencies can cause immune dysregulation. In human medicine, 
protein-energy malnutrition, as well as a number of micronutrient deficiencies are known to 
impair immune responses (reviewed in Calder, 2013). Zinc deficiency is classically associated 
with reductions in thymus weight and circulating lymphocytes, as well as retarded healing and 
increased risk of secondary infections (reviewed in Fraker and King, 2004). 
In cattle, severe zinc deficiency leads to multiple quantifiable impacts on immune 
function. One convenient model which has been extensively used to study zinc deficiency in 
cattle is autosomal recessive bovine hereditary zinc disorder (BHZD). As discussed above, 
BHZD is caused by a mutation in the gene encoding an important zinc transporter for dietary 
zinc uptake. Calves born with BHZD exhibit signs closely resembling diet-induced zinc 
deficiency—diarrhea, lethargy, delayed wound healing, etc.—which are reversible with addition 
of zinc to the diet (Machen et al., 1996). Perryman et al. (1989) observed marked reduction in 
lymphocyte activity in BHZD calves. Reduced thymus weights are another feature of BHZD 
(Brummerstedt, 1971). Calves in controlled studies modeling diet-induced zinc deficiency also 
exhibit changes to the immune system. Miller et al. (1965b) showed that zinc deficient calves 
experienced delayed and abnormal healing compared to control calves. 
Moderate zinc deficiencies leading to negative impacts on production often do not impact 
immune function. Supplementing zinc to a practical ration for growing heifers did not impact 
lymphocyte activity (Kincaid et al., 1997). Likewise, lymphocyte activity and swelling response 
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of grower-finisher steers on a practical diet did not respond to zinc supplementation (Spears and 
Kegley, 2002). 
However, in some scenarios, zinc supplementation to practical diets has led to enhanced 
immune response compared to unsupplemented animals. Zinc supplements decreased recovery 
time following an infectious bovine rhinotracheitis challenge in feedlot steers (Chirase et al., 
1991). Also, lactating dairy cows receiving an ostensibly more bioavailable source of zinc had 
lower somatic cell counts in milk and higher IgG levels in colostrum than control cows receiving 
a zinc sulfate supplement (Nayeri et al., 2014). 
Research in rodent models has illuminated numerous cellular and biochemical 
interactions between zinc status and immunity. Diet-induced zinc deficiency in mice leads to 
thymic atrophy, as well as decreased numbers of lymphocytes, particularly the immature B cells 
(King et al., 1995). While total numbers of circulating lymphocytes decline in zinc deficient 
mice, the functionality of the remaining cells remains the same (Cook-Mills and Fraker, 1993). 
Concurrent with immune suppression, zinc deficiency coincided with increased levels of 
circulating glucocorticoids (GC; King et al., 1995), implicating the adrenocortical axis in this 
process. In an attempt to further explore the role of GC, DePasquale-Jardieu and Fraker (1980) 
compared adrenalectomized and sham-operated mice with and without zinc deficiency. 
Interestingly, removal of the adrenal gland (and subsequent drops in circulating corticosterone) 
completely protected zinc deficient mice from thymic atrophy. Considering the nutritional 
demands of a normally-functioning immune system, it has been proposed that immune 
suppression such as that described above may have a nutrient-sparing effect in animals 
experiencing a variety of deficiencies (reviewed in Fraker et al., 1995). 
17 
 Integumentary effects 
The effects of zinc on the integumentary system are also widespread and profound. 
Perhaps the most characteristic signs of zinc deficiency are the skin disorders which accompany 
it. In cattle, hair loss, parakeratosis, and various skin lesions are observed in calves and cows 
following zinc deficiency (Legg and Sears, 1960). In vitro, zinc has been shown to prevent 
apoptosis and promote proliferation in a variety of epithelial cell lines, including intestinal 
(Cohen et al., 2012, 2014), airway (Truong-Tran et al., 2003), and mammary (Hennigar et al., 
2015) epithelial cells. In a mouse model, moderate zinc deficiency has been shown to 
dramatically impact apoptosis, lactation rates, and gross morphology of the lactating mammary 
gland (Dempsey et al., 2012). In cattle, feeding a greater proportion of zinc as an ostensibly more 
bioavailable amino acid complex results in increased milk production and improved mammary 
health in multiparous cows (Nayeri et al., 2014). Whether the improved performance is a 
reflection of enhanced immune response or a direct effect on the milk-secreting epithelial cells is 
not yet known. 
 
 Conclusion 
The importance of zinc in the diet of cattle is readily illustrated by the extensive and 
diverse complications associated with its deficiency. Many benefits of zinc supplementation have 
been documented in beef and dairy cattle. However, the cellular and biochemical mechanisms 
remain, for the most part, to be elucidated. Basic research in rodent models provide a number of 
tantalizing hints about the mechanisms behind production improvements in response to zinc 
supplementation. As methods for the study of these basic mechanisms become more readily 
18 
available, thorough descriptions of the biochemistry of zinc specifically in the bovine may soon 
become a reality. 
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Chapter 2 - Effects of dietary zinc amino acid complex on mammary 
epithelium and dairy food chemistry 
  
 Abstract 
Twelve lactating Holstein cows (132 ± 21 DIM) were enrolled in a replicated 3 x 3 Latin 
square experiment to explore the extent to which the source and amount of supplemental Zn in 
the diet of lactating cows can impact the structure of mammary epithelial tissue. Cows received 
either 0.97 g supplemental Zn/d as ZnSO4 (34.5 mg Zn/kg DM; 30-ZS), 1.64 g supplemental 
Zn/d as ZnSO4 (56.5 mg Zn/kg DM; 60-ZS), or 1.68 g supplemental Zn/d as a mixture of ZnSO4 
and Zn methionine (58.2 mg Zn/kg DM; 60-ZM). Treatments lasted for 17 days followed by 4 
days of sample collection. Blood and milk were collected and analyzed for markers of blood-
milk leak including plasma lactose and α-lactalbumin, and blood and milk electrolytes. Total 
RNA was also isolated from milk cells, and abundance of ZnT2 and clusterin, genes with 
potential impact on Zn-dependent apoptosis, were measured. Finally, dairy food properties of 
milk (heat coagulation time, nonprotein nitrogen, and noncasein nitrogen) were also analyzed. 
60-ZS cows tended to have greater feed intake than 30-ZS (P = 0.06), and milk fat percentage 
tended to be greater for 60-ZM compared to 30-ZS (P = 0.08). No other effects on milk 
composition, yield, or production efficiency were observed. No effects were observed on 
markers of blood-milk leak, RNA abundance of ZnT2 or clusterin, or properties of dairy food 
chemistry. Concentration and source of dietary Zn did not impact mammary epithelial integrity 
in lactating cows during late lactation. 
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 Introduction 
Dietary zinc is important for immunity, reproduction, hormone activity, and the activity 
of many enzymes in dairy cattle (NRC, 2001). Zinc availability has been shown to impact 
apoptosis in different epithelial cell lines and tissue types. Cohen et al. (2014, 2012) described a 
zinc signaling pathway in colonocytes in which extracellular zinc influences the expression of 
the antiapoptotic protein, clusterin. Mammary epithelial cells (MECs) may also be sensitive to 
zinc availability. Dempsey et al. (2012) have shown in a mouse model that moderate zinc 
deficiency can impact apoptosis rate, gross morphology, and milk secretion in the mammary 
gland of mice. Hennigar et al. (2015) have further shown that overexpression of the zinc 
transporter, ZnT2, stimulates lysosomal-mediated cell death in the mouse mammary gland.  
Research in applied nutrition has shown that supplementing zinc as a zinc amino acid 
complex increases milk production in dairy cattle, likely due to an increased bioavailability of 
the zinc (Kellogg et al., 2004). In addition to production benefits, Nayeri et al. (2014) observed 
decreased milk somatic cell counts and increased colostrum IgG in multiparous cows fed 
increased proportions of zinc as a zinc amino acid complex.  
Blood lactose and α-lactalbumin, milk albumin, and the ratio of blood electrolytes:milk 
electrolytes have been used as biomarkers for blood-milk leak in previous research (Stelwagen et 
al., 1997, 1995, 1994). In this study, we explored the extent to which variable sources and levels 
of zinc supplementation in practical rations impact MEC structure and apoptosis. We 
hypothesized that cows fed higher concentrations or more bioavailable zinc would show fewer 
signs of cellular degeneration and epithelial permeability in the mammary gland. 
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 Methods 
 Cows and treatments 
Twelve multiparous Holstein cows in mid- to late-lactation (132 ± 21 DIM) were 
enrolled in a replicated 3 × 3 Latin square experiment. Cows were blocked by average milk yield 
(51 ± 3 kg/d) and randomly assigned to treatment sequence within block. The experiment was 
divided into 3 periods of 21 days, with 17 days of diet adaptation and 4 days of sample collection 
in each period. Throughout the course of the study, cows were housed in individual tie stalls 
equipped with automatic waterers, provided with a balanced basal ration (Table 2.1) fed twice 
daily at 0700 h and 1600 h to provide 110% of expected intake, and milked 3 times daily at 0700 
h, 1600 h, and 2300 h.  
Treatments consisted of (1) 0.97 g Zn/d provided as ZnSO4 (34.5 mg Zn/kg diet DM; 30-
ZS), (2) 1.64 g Zn/d as ZnSO4 (56.5 mg Zn/kg diet DM; 60-ZS), and (3) 0.55 g Zn/d provided as 
ZnSO4 plus 1.13 g Zn/d provided as a zinc methionine complex (58.2 mg Zn/kg diet DM; 60-
ZM). Treatments were administered once daily at 1700 h as an oral bolus (Torpac, size #10, 
Valley Vet Supply, Marysville, KS) containing all supplemental trace minerals except for Se, 
which was included in the grain mix. All trace minerals except for Zn were provided in equal 
amounts across treatments. Smartamine M (Adisseo Inc., France) was also included in the 30-ZS 
and 60-ZS boluses to provide metabolizable methionine equivalent to that provided in 60-ZM 
(Table 2.2).  
An additional cow (second lactation, 128 DIM) was kept throughout the first treatment 
period as a potential replacement, fed the same basal diet, and received the 60-ZS treatment 
bolus daily. Data from this replacement cow for the first treatment period were included in 
analysis. During the second treatment period, one cow developed a case of clinical mastitis, was 
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removed from the study, and period 2 and 3 data this cow were excluded from analysis. Also, 
during the third treatment period, one cow became lame, suffered a drop in intake, and was 
removed from the study; period 3 data from this cow were excluded from analysis. In total, 34 
cow × period observations were included in the analysis. 
Data collection and sampling procedures 
Initial body weights were measured on the first day of the study, refusals were weighed 
daily to monitor feed intake, and water intake was recorded daily using in-line meters on each 
waterer. During sampling periods, milk samples (~ 25 mL) were collected at each milking for 
component analysis by DHIA (MQT Labs, Kansas City, MO). Additional milk samples (≥ 20 
mL) were collected and stored at -20°C for later analysis. On the last day of each sampling 
period, 2 additional milk samples were collected at the morning milking (0700 h). One sample 
(~2 L) was analyzed that day for heat stability and prepared for analysis of protein fractions. The 
second sample (50 mL) was immediately placed on ice and centrifuged within 30 min of 
collection (15 min, 3,000 × g, 4°C). The pellet was then suspended in TRIzol reagent (Thermo 
Fisher Scientific, Inc.) and stored at -80°C until later analysis of RNA transcript abundance. 
On either the third or fourth day of each sampling period, blood samples were collected 
in K3EDTA tubes via coccygeal venipuncture at 0900 h, 1100 h, 1300 h, and 1500 h. Blood 
samples were centrifuged for 15 min at 1500 × g and plasma was collected and stored at -20°C 
for later analysis of α-lactalbumin and lactose concentrations. An additional blood sample was 
collected at 1300 h in Li heparin tubes and whole blood was immediately analyzed for Na, K, 
and Cl concentrations as well as hematocrit and hemoglobin, using a handheld blood analyzer 
(VetScan i-STAT 1; E3+ cartridges; Abaxis, Union City, CA).  
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 Milk sample preparation and analyses 
Milk samples (n = 12/cow per period) were defatted and composited for each cow within 
each treatment period. Briefly, sample tubes were brought to 33°C in a water bath, inverted 4 
times, and centrifuged for 30 min at 3,000 × g and 4°C. The fat layer was removed and equal 
proportions of the aqueous phase were combined into a sterile microcentrifuge tube. Composited 
samples were then centrifuged a second time (60 min, 15,000 × g, 4°C). The translucent 
supernatant was used for quantification of electrolytes. Sodium and potassium concentrations 
were determined using atomic absorbance spectrophotometry (model 3110, Perkin Elmer, 
Waltham, MA) measured at 589 nm and 766.5 nm for Na and K respectively. Attempts were also 
made to measure bovine albumin concentrations in milk using a commercially available kit 
(Bethyl Laboratories, Inc.; Montgomery, TX). Inter-assay CV for technical replicates of samples 
averaged 35% for this assay. Eight ng of bovine albumin was spiked into 100 μL of 4 samples 
with CV < 15%, but recovery averaged -19% (absorbance decreased relative to the unspiked 
samples). Because of the poor performance of this assay, albumin concentrations were not 
considered in our analysis. 
Whole milk samples (~2 L) collected on the final day of each treatment period were kept 
on ice immediately following collection and used the same day for determination of heat 
coagulation time (HCT) and quantification of nonprotein nitrogen (NPN) and noncasein nitrogen 
(NCN). Heat coagulation time was performed following the method of Davies and White (1966) 
with minor modifications. Briefly, 5 subsamples were allowed to equilibrate to room temperature 
and adjusted to different pH’s (pH 6.4, 6.6, 6.8, and 7.0, and native pH) using 0.5 N NaOH or 
HCl. Three mL of each subsample were collected into a tightly-capped glass test tube and placed 
on a rocker. The rocker was immersed in an oil bath (140°C) and monitored visually. HCT was 
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recorded as the time (min) required for the onset of visible clots. NPN and NCN were measured 
as described by Zhang and Metzger (2011). 
 Plasma sample preparation and analyses 
Plasma samples (n = 4/cow per period) were composited in duplicate for each cow within 
each treatment period. Composited plasma samples were diluted 1:15 and the concentration of 
bovine α-lactalbumin was measured by ELISA using a commercially available kit (Bethyl 
Laboratories, Inc.; Montgomery, TX) according to the manufacturer’s protocol. Samples were 
analyzed in duplicate on a single plate and the mean intra-assay CV was 25%. To test the validity 
of the assay in our samples, 0.05 ng of bovine α-lactalbumin was spiked into 100 µL of 4 
representative samples (5 ng/mL spike). The mean recovery was 75 ± 38%. Because of the 
variability in results obtained with this kit, analysis of bovine α-lactalbumin should be 
interpreted with caution.  
Composited plasma samples were also deproteinized for measurement of lactose. Briefly, 
30 µL of 6 N HClO4 was added to 300 µL of composited plasma. Samples were kept on ice for 
20 min and centrifuged for 2 min at 10,000 × g. Two hundred µL of supernatant were collected 
in a fresh tube containing 18 µL of 6 N KOH. Tubes were left on ice for another 20 min, 
centrifuged for another 2 min at 10,000 × g, and the supernatant was collected for analysis of 
lactose concentration. Lactose concentration was measured in the deproteinized plasma using a 
commercially available kit (Abnova, Taiwan) according to the manufacturer’s protocol. Samples 
were analyzed in duplicate on 2 plates. The mean intra-assay CV was 22%. To test the validity of 
the assay, 4 nmol lactose was spiked into 20 µL of a representative sample (200 μM spike) and 
recovery was measured at 118%.  
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 Milk mRNA isolation and abundance 
RNA was isolated from whole milk pellets using the RNeasy Mini procedure (Qiagen). 
Concentration of RNA was measured on a NanoDrop ND-1000 spectrophotometer (Thermo 
Fisher Scientific, Inc.) and used to determine volumes for reverse transcription. The amount of 
RNA used for reverse transcription ranged from 78.6 to 431.4 ng. 
Reverse transcription was performed on a DCL 25 thermal cycler (Dynalab Corp.; 
Rochester, NY) using iScript Reverse Transcription Supermix (Bio-Rad Laboratories, Inc.; 
Hercules, CA). The resulting cDNA was amplified with primers for ZnT2, clusterin, occludin, 
RPS9, and RPS15 on a 7500 Fast Real-Time PCR System (Thermo Fisher Scientific, Inc.) using 
iTaq Universal SYBR Green Supermix (Bio-Rad Laboratories, Inc.; Hercules, CA). Normalized 
transcript abundance was calculated for ZnT2, clusterin, and occludin using the ΔΔCT method 
with the geometric mean of RPS9 and RPS15 as control genes, and a mix of all samples as a 
reference sample. Primers were designed using the Primer-BLAST tool on the National Center 
for Biotechnology Information website (Table 2.3).  
 Statistical analyses 
Measurements were analyzed in JMP v10.0 (SAS Institute, Cary, NC) with a mixed 
model using fixed effects of treatment and period, and the random effect of cow. Significance 
was declared at P < 0.05 and tendencies at P < 0.10. Interactions of treatment and period were 
also tested and removed from the model if they did not contribute (P > 0.10). 
 Results 
Feed intake tended to be greater for 60-ZS cows (P = 0.06) compared to 30-ZS, and milk 
fat percentage tended to be greater for 60-ZM (P = 0.08) compared to 30-ZS. No other effects on 
milk composition, yield, or production efficiency were observed (Table 2.4). This study was not 
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designed to be sensitive enough to detect modest production effects. However, previous research 
has shown increases in milk production when feeding higher proportions of Zn as a Zn-amino 
acid complex (Kellogg et al., 2004).  
Plasma electrolyte, lactose and α-lactalbumin concentrations were also unaffected by 
treatment, as were milk electrolytes (Table 2.5). No effects of treatments were observed on heat 
coagulation time or the proportion of nonprotein nitrogen or noncasein nitrogen in the milk 
(Table 2.6).  
No treatment effects were observed in transcript abundance of ZnT2 or clusterin in milk 
cells (Table 2.5). Occludin transcript abundance was too low to reliably measure in our samples. 
 Discussion 
Results from this study indicate that supplemental zinc source and level in practical diets 
of lactating dairy cattle have little effect on the integrity of the blood-milk barrier of the healthy 
mammary gland. In previous research, plasma lactose and α-lactalbumin levels have been shown 
to increase with disruption of the epithelial barrier separating blood from milk in the mammary 
gland (Stelwagen et al., 1997). The lack of treatment effects observed in this study likely 
indicates that epithelial integrity was not appreciably affected by our treatments, perhaps in part 
due to the use of healthy, non-mastitic cows. 
Feeding of marginally zinc-deficient diets in early lactation has been shown to increase 
somatic cell counts in dairy cattle (Cope et al., 2009). Further, multiparous cows supplemented 
with an increased proportion of zinc as zinc methionine had reduced somatic cell counts and 
higher colostrum IgG (Nayeri et al., 2014), indicating improved mammary health and possibly 
enhanced immune function. One possible explanation for this observation is that zinc 
supplementation leads to less apoptosis in the mammary gland, leading to a tighter blood-milk 
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barrier. Marginally zinc deficient mice have been shown to experience dramatic increases in 
apoptosis rates in mammary tissue leading to differences in gross morphology of the mammary 
gland during lactation (Dempsey et al., 2012). Were this the case for our model, we would likely 
have observed differences in markers of blood-milk leak. 
Another potential explanation for zinc supplementation leading to improved mammary 
health is a direct impact on immune responses. Dietary zinc levels impact lymphocyte numbers 
as well as other aspects of the immune response in mice (reviewed in Fraker and King, 2004); 
however, zinc supplementation in practical diets of cattle does not always impact measures of 
immune function (Kincaid et al., 1997; Spears and Kegley, 2002). It is possible that the 
improvements in mammary health and milk production noted in previous studies were the 
product of improved immune response to mastitis challenge, without directly affecting apoptosis 
of mammary epithelial cells or integrity of the blood-milk barrier.  
Transcript abundance of selected genes was determined as a further exploratory attempt 
to discover cellular pathways impacted by zinc supplementation in the mammary gland. 
Collecting RNA from an internal tissue of a living organism is typically a difficult task, requiring 
a biopsy procedure. In the case of mammary epithelial cells, there are alternatives to biopsy, 
which in turn present their own challenges. In the present study, we utilized milk somatic cells as 
a source of mammary tissue. Isolation of RNA from milk somatic cells has been shown to 
produce RNA sequencing results comparable to other more intensive sampling methods such as 
biopsies, laser-capture of cells from fixed tissue, and antibody-capture of milk epithelial cells 
(Canovas et al., 2014). However, in a healthy cow, less than 10% of milk somatic cells are 
expected to be MEC (Wagner et al., 2009), with the balance largely made up of immune cells. It 
is possible that transcript abundance of genes expressed preferentially in MEC could be diluted 
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by the low proportion of MEC in milk somatic cells. Abundance was low for all of our chosen 
transcripts (Table 2.3), which may partially explain why no differences were detected. 
ZnT2 is a zinc transporter which is involved in zinc transport into milk (Chowanadisai et 
al., 2006), as well as participating in lysosomal-mediated cell death during mammary involution 
(Hennigar et al., 2015). Dempsey et al. (2012) found that transcript abundance of ZnT2 was 
higher in mice fed a marginally zinc-deficient diet throughout gestation and lactation. This was 
coupled with decreased milk secretion and increased numbers of apoptotic cells in the mammary 
gland. In the present study, all cattle were fed a diet which met NRC (2001) requirements for 
daily zinc intake, and treatment diets were administered for only a portion of the lactation period, 
in order to facilitate a Latin square experimental design. Although no effects were detected in the 
current study, this does not rule out the possibility that a marginally zinc-deficient diet, or 
provision of a supplement for an extended period of time may elicit a response in ZnT2 
expression. 
Clusterin is a ubiquitously-expressed protein which is upregulated by cellular stress in a 
diverse array of tissue types and prevents apoptosis by reducing oxidative stress (reviewed in 
Park et al., 2014). Further, clusterin is associated with drug resistance in a variety of tumor cells, 
and is upregulated in prostate, renal, colon, breast, and other cancer cells in humans (reviewed in 
Djeu and Wei, 2009). Cohen et al. (2012) found that 100 µM zinc caused increased clusterin 
expression in butyrate-challenged HT29 colonocytes. It is important to note that butyrate 
treatment was necessary for extracellular zinc to impact clusterin expression, and that in the 
absence of cellular stress, there was no zinc effect. In the present study, the lack of response in 
clusterin expression may be due to a lack of cellular stress in the mammary gland. The study was 
conducted during post-peak lactation, a period where cellular stability is relatively high, in 
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healthy animals. In mastitic cows, or during involution, clusterin regulation may be more 
dramatic.  
 Conclusion 
Zinc supplementation of dairy rations at 30 ppm as opposed to 60 ppm did not appear to 
impact the integrity of the blood-milk barrier or dairy food properties of milk, nor did the 
inclusion of a greater proportion of the Zn as an amino acid complex. Milk production responses 
to amino acid-bound zinc sources which have been documented in studies with larger sample 
sizes are likely due to mechanisms other than a direct impact on mammary epithelial integrity. 
However, it is possible that these treatments could elicit a response in cohorts with greater 
mastitis pressure, with more challenges to mammary epithelial integrity. 
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Table 2.1 Formulation and composition of basal diet 
Item Value 
Ingredient, % of diet DM  
Alfalfa hay 18.6 
Corn silage 18.9 
Wet corn gluten feed1 24.3 
Cotton seed 4.3 
Lactation grain mix2 33.9 
  
Nutrient, % of diet DM unless specified  
DM, % as-fed 53.4 
CP 17.9 
ADF 19.3 
aNDF 30.4 
Lignin (Sulfuric Acid) 4.7 
NFC 42.1 
Fat (EE) 4.4 
Zinc, ppm 58.3 
NEL
3, Mcal/kg 1.6 
 
1Sweet Bran (Cargill Inc., Blair, NE) 
2Lactation grain mix consisted of 66.22% fine rolled corn, 20.2% expeller soybean meal 
(SoyBest, Grain States Soya, West Point, NE), 4.04% limestone, 0.5% stock salt, 0.5% 
potassium chloride, 3.53% sodium bicarbonate, 0.81% magnesium oxide, 0.13% selenium 
premix (0.06% Se from sodium selenite), 0.05% vitamin A premix (30 kIU/g), 0.02% vitamin D 
premix (30 kIU/g), 0.5% vitamin E premix (44 IU/g), 0.02% Rumensin 90 (Elanco Animal 
Health, Greenfield, IN), 0.63% XP Yeast (Diamond V, Cedar Rapids, IA), 0.32% Biotin 100 
(ADM Alliance Nutrition, Quincy, IL), 2.52% Ca salts of long-chain fatty acids (Megalac R, 
Arm & Hammer Animal Nutrition, Princeton, NJ) 
3Estimated according to NRC (2001) 
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Table 2.2 Treatment bolus composition and nutrient supply 
Item1 30-ZS 60-ZS 60-ZC 
DM, % 97.97 98.28 97.74 
Ca, % DM 1.55 1.33 5.23 
P, % DM 0.01 0.01 0.01 
Mg, % DM 0.13 0.10 0.11 
K, % DM 0.23 0.21 0.26 
S, % DM 15.42 15.31 10.35 
Mn, % DM 12.84 9.95 9.69 
Zn, % DM 7.99 11.55 10.37 
Cu, % DM 1.89 1.40 1.32 
Fe, % DM 0.23 0.26 0.23 
Na, % DM 2.61 1.94 2.01 
Cl, % DM 2.32 2.42 8.83 
DCAD, mEq/100g -909.72 -935.44 -801.66 
Dose2, grams/day    
Ca 0.19 0.19 0.85 
P 0.00 0.00 0.00 
Mg 0.02 0.01 0.02 
K 0.03 0.03 0.04 
S 1.87 2.17 1.68 
Mn 1.56 1.41 1.57 
Zn 0.97 1.64 1.68 
Cu 0.23 0.20 0.21 
Fe 0.03 0.04 0.04 
Na 0.32 0.28 0.32 
Cl 0.28 0.34 1.43 
Met3 2.71 2.71 2.69 
Metabolizable Met3 2.19 2.19 2.18 
 
1Values are results of analysis of mineral mixes (Dairyland labs, Arcadia, WI). 
2Doses are calculated using observed average daily intakes. 
3Methionine supplied from Zinpro 120 (27.3% methionine, 90% bypass, AA digestibility of 
90%; Zinpro Corp., Eden Prairie, MN) or Smartamine M (70% methionine. 90% rumen bypass, 
90% intestinal digestibility; Adisseo USA Inc., Alpharetta, GA) 
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Table 2.3 Primers used for RT-qPCR 
Gene 
Accession 
number 
Forward primer 
Reverse primer 
Region 
amplified 
Reaction 
Efficiency 
Mean 
CT 
ZnT2 NM_001191496.1 
AGCTTGCAGTCGGGACTTAC 
CCAGGACCCTTCTGGGAATG 
38 – 176 91% 32.09 
Clusterin XM_005209841.1 
GATTGATTGGTGCTGCCTGC 
CACCTCTCTTGGGTCACTCG 
88 – 214 71% 31.15 
Occludin NM_001082433.2 
TACCACTCCTCCTCCCTAGC 
AGATCAGCCAATCTGCGGCT 
55 – 180 undetermined 35.34 
RPS9 DT860044.1 
GAACAAACGTGAGGTCTGGAGG 
ATTACCTTCGAACAGACGCCG 
233 – 344 106% 22.44 
RPS15 NM_001024541.2 
GGCGGAAGTGGAACAGAAGA 
GTAGCTGGTCGAGGTCTACG 
23 – 96 99% 21.93 
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Table 2.4 Intake and milk production 
 Least Square Means  Prob > F 
Item 30-ZS 60-ZS 60-ZM SEM Trt Period 
DMI, kg/d 28.15 29.01 28.88 0.65 0.06 < 0.001 
Zn intake, g/d   2.61a   3.33b   3.37b 0.04 < 0.001 < 0.001 
Milk, kg/d 47.23 47.34 47.79 1.34 0.74 0.16 
ECM, kg/d 48.03 48.88 49.58 1.17 0.36 0.23 
Milk/DMI   1.68   1.63   1.66 0.04 0.13 < 0.001 
ECM/DMI   1.71   1.69   1.73 0.03 0.42 < 0.001 
Milk protein, %   3.04   3.03   3.02 0.06 0.52 < 0.001 
Milk protein, kg/d   1.43   1.43   1.44 0.04 0.97 0.25 
Milk fat, %   3.56   3.69   3.76 0.13 0.08 0.35 
Milk fat, kg/d   1.67   1.74   1.78 0.06 0.15 0.17 
Milk lactose, %   4.90   4.94   4.91 0.04 0.21 0.098 
Milk lactose, kg/d   2.31   2.33   2.34 0.06 0.71 0.09 
SCC LS1   1.35   1.18   1.55 0.30 0.30 0.96 
MUN, mg/dL 13.15 13.53 13.49 0.50 0.23 0.21 
1SCC linear score (LS) calculated using the formula, LS = log2 (SCC/100) + 3, where SCC = 
number of somatic cells/µL of milk (Schukken et al., 2003). 
a bWithin row, values not sharing common superscript differ (P < 0.01). 
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Table 2.5 Mammary epithelial integrity markers 
 Least Square Mean  Prob > F 
Item 30-ZS 60-ZS 60-ZM SEM Trt Period 
Blood K, mM 4.35 4.59 4.36 0.09 0.12 0.11 
Blood Na, mM 136.86 136.47 136.31 0.38 0.52 0.57 
Blood Cl3, mM 99.52 99.84 99.82 0.52 0.80 0.43 
Blood Hb3, *mM 5.62 5.70 5.67 0.07 0.48 0.04 
Blood Hct3 (% PCU) 26.58 27.00 26.85 0.33 0.48 0.04 
Plasma lactose, µM 21.32 20.91 19.14 2.35 0.73 0.53 
Milk Na1, ppm 354 349 369 11 0.15 < 0.001 
Milk K, ppm 1516 1492 1527 30 0.55 < 0.01 
ZnT2, NTA2 0.59 0.39 0.35 0.15 0.25 0.054 
Clusterin, NTA 2.27 0.98 1.20 0.72 0.41 < 0.01 
1Modeled with blood Na as a covariate (P < 0.01) 
2NTA = Normalized transcript abundance 
3Treatment × period effect significant and included in the model (P < 0.1) 
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Table 2.6 Dairy food chemistry 
 Least Square Mean  Prob > F 
Item 30-ZS 60-ZS 60-ZC SEM Trt Period 
Milk NPN, ppm 286 306 296 12 0.51 < 0.01 
Milk non-casein N1, ppm 791 816 809 42 0.92 0.052 
Native HCT1, min 11.29 11.35 10.89 1.66 0.78 0.19 
6.4 HCT, min 0.90 1.35 2.80 0.27 0.40 0.09 
6.6 HCT, min 12.31 12.46 11.20 0.77 0.39 0.87 
6.8 HCT, min 12.28 12.98 13.03 1.68 0.89 0.22 
7.0 HCT, min 12.12 10.17 10.41 1.68 0.59 0.33 
1Treatment × period effect significant and included in the model (P < 0.1) 
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Chapter 3 - Effects of extracellular Zn and Zn receptor GPR39 on 
ERK and AKT phosphorylation in bovine mammary epithelial cells 
 
Abstract 
The orphaned G protein-coupled receptor, GPR39, has been shown to regulate cellular 
proliferation and apoptosis in response to extracellular zinc in a variety of tissues and cell lines. 
To explore if a similar mechanism exists in bovine mammary epithelia, GPR39 was knocked 
down at the mRNA level using RNA interference in immortalized bovine mammary epithelial 
(MAC-T) cells. Twenty-four hours post-transfection, control and siRNA-treated cells were 
treated with either 0 or 100 µM Zn and harvested for measurement of total and phosphorylated 
ERK1/2 and AKT. Two siRNA constructs (siGPR39a and siGPR39b) were tested for 
knockdown efficiency of GPR39. At the high-Zn level, transcript abundance of GPR39 was 
reduced 63% by siGPR39a (P = 0.02) and 57% by siGPR39b (P = 0.04). Interestingly, there was 
a tendency for Zn to increase abundance of GPR39 in cells not treated with siRNA (P = 0.096). 
Phosphorylation of ERK1/2 and AKT was not affected by knockdown of GPR39 or Zn 
treatment. Given the response in GPR39 mRNA abundance to extracellular Zn, it is possible that 
GPR39 possesses Zn-dependent functions in MAC-T cells. However, extracellular Zn and 
knockdown of GPR39 do not impact phosphorylation of ERK or AKT, key intermediates of 
common kinase signaling cascades. 
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Introduction 
Zinc has long been recognized as an essential component of the diet of cattle (Legg and 
Sears, 1960). As such, its supplementation to diets is not only advisable, but occasionally 
necessary for normal growth, development, and health of the animal. Severe Zn deficiency leads 
to sudden and drastic consequences on health and production, which are just as quickly reversed 
by addition of Zn to the diet (reviewed in Miller, 1970).  
Improvements in production can also be realized by Zn supplementation to practical 
diets. For instance, Spears and Kegley (2002) noted improved average daily gain and carcass 
quality in grower/finisher steers supplemented with 25 mg Zn/kg diet dry matter. Also, Cope et 
al. (2009) have shown that provision of approximately 1.4 g Zn/cow per day effectively reduced 
milk somatic cell counts and amyloid A content compared to cattle fed approximately 0.9 g 
Zn/cow per day. 
Further production benefits have been reported by supplementing with ostensibly more 
bioavailable Zn sources. Greene et al. (1988) found that steers supplemented with Zn methionine 
showed improvements in carcass quality compared to Zn oxide-supplemented controls. More 
recently, Nayeri et al. (2014) observed a marked decrease in milk somatic cells and an increase 
in colostrum IgG of multiparous cows, as well as increased milk production in all cows receiving 
a higher proportion of supplemental Zn as an amino acid complex. However, little is known 
about the molecular mechanisms by which supplemental Zn can support increased milk yield or 
quality. 
One interesting possibility is the potential for Zn to act as a signaling ligand, altering 
cellular function in various tissues. Currently, the best-characterized example of a mineral which 
actively participates in cellular signaling is calcium, which regulates a variety of cellular 
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activities in a number of tissue types in addition to the classical regulation of parathyroid 
hormone secretion (reviewed in Chattopadhyay, 2000). Recently, another G protein-coupled 
receptor, GPR39, which responds to Zn as a ligand, has been characterized in intestinal, salivary 
gland, and keratinocyte cell lines (Hershfinkel et al., 2001; Cohen et al., 2014) as well as mouse 
neural tissue (Besser et al., 2009). Cohen et al. (2014) have shown that GPR39 mediates a Zn-
dependent increase in activity of the MAPK and PI3K signaling cascades in HT29 colonocytes, 
as well as a Zn-dependent increase in cellular proliferation. In other tissue types, GRP39 has 
been observed to mediate a Zn-dependent release of intracellular calcium stores (Hershfinkel et 
al., 2001).  
The rapidity with which cattle are affected by Zn deficiency, coupled with the small 
change in tissue Zn content (reviewed in Miller, 1970, 1969), would fit with the idea of a Zn-
sensing receptor, which could impact cellular function without changing the cellular Zn content. 
The purpose of this study was to determine whether the putative Zn receptor, GPR39, is 
expressed in the immortalized bovine mammary epithelial cell line, MAC-T, and if so, to explore 
its role in regulating function of these cells. 
 Methods 
 Cell Culture and Transfection 
Immortalized bovine mammary epithelial (MAC-T) cells were cultured in DMEM with 
10% FBS, 50 µg/mL gentamycin, 20 µg/mL streptomycin, 20 units/mL penicillin, and 5 µg/mL 
insulin (growth medium) in an incubator at 37°C and 5% CO2. Cells were cultured in two 12-
well plates for 24 hours (~80% confluence) and subsequently transfected using the TransIT X2 
Dynamic Delivery System (Mirus Bio) following manufacturer’s protocol, with minor 
modifications. Prior to transfection, siRNA/transfection reagent complexes were prepared in a 
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reduced serum medium (Opti-MEM, Thermo Fisher Scientific) and allowed to incubate 15 
minutes at room temperature. Cells were then washed once with Ca++/Mg++-free PBS, immersed 
in Opti-MEM (300 µL/well), and transfected with either: a) one of two siRNA constructs 
designed to knock down GPR39 (Table 3.1), or b) a universal negative control (Sigma Life 
Science, cat # SIC001). All wells contained a final concentration of 0.27% TransIT X2 and 45 
nM siRNA. Following transfection, plates were incubated at 37°C, 5% CO2 for 4 hours. At that 
time, 600 µL growth medium was added back to each well, and cells were incubated for another 
20 hours (37°C, 5% CO2).  
 Kinase Activation 
Twenty-four hours after transfection, cells were removed from the incubator and tested 
for kinase activation following a Zn treatment. Briefly, wells were washed once with Hanks 
Balanced Salt Solution (HBSS), and 1 mL of either 0 or 100 µM Zn in HBSS was added to each 
well. Wells were incubated for 10 minutes in the incubator (37°C, 5% CO2). Following 
incubation, wells were washed and incubated a second time with only HBSS (10 minutes, 37°C, 
5% CO2) to allow completion of phosphorylation. After the second 10-min incubation, cells 
were washed with cold PBS and suspended in 300 µL Cell Disruption Buffer (Thermo Fisher 
Scientific) + 0.5% phenylmethane sulfonyl fluoride. 
 RNA/Protein Isolation and RT-qPCR 
Following kinase activation, protein and RNA were isolated from cells using the mirVana 
PARIS kit (Thermo Fisher Scientific). Concentration of RNA was measured on a NanoDrop ND-
1000 spectrophotometer (Thermo Fisher Scientific) and used to determine sample volumes for 
reverse transcription. 
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Reverse transcription was performed on a DCL 25 thermal cycler (Dynalab Corp.; 
Rochester, NY) using iScript Reverse Transcription Supermix (Bio-Rad Laboratories, Inc.; 
Hercules, CA). The resulting cDNA was amplified with primers for GPR39, RPS9, and RPS15 
on a 7500 Fast Real-Time PCR System (Thermo Fisher Scientific, Inc.) using iTaq Universal 
SYBR Green Supermix (Bio-Rad Laboratories, Inc.; Hercules, CA). Normalized transcript 
abundance was calculated for GPR39 using the ΔΔCT method with the geometric mean of RPS9 
and RPS15 as control genes, and a mix of all samples as a reference sample. Primers for GPR39 
were designed using the Primer-BLAST tool on the National Center for Biotechnology 
Information website (Table 3.2).  
 Western Blotting 
Protein concentration of cell lysates were determined as described by Bradford (1976). 
Samples were electrophoresed on two 4-12% Tris Glycine gels for 1 hour at 225 V. Loading 
volumes were calculated to contain 20 µg protein. Following electrophoresis, gels were blotted 
to nitrocellulose membranes using the iBlot 2 Dry Blotting System (Thermo Fisher Scientific). 
Membranes were sequentially probed for AKT1/2/3, pAKT1/2/3, ERK1/2, and pERK1/2. 
Briefly, membranes were blocked with 0.1 M Tris-HCl containing 5% dry milk and 1% BSA. 
Following blocking, membranes were washed and left overnight with the appropriate primary 
antibody at 4°C. The next day, membranes were incubated for 1 h with the corresponding 
secondary antibody-HRP conjugate in 0.1 M Tris-HCl containing 5% dry milk. After this, bands 
were detected on a photodocumentation system using Pierce ECL Western Blotting Substrate 
(Thermo Fisher Scientific). Densitometric analysis was performed on the bands using the gel 
analysis tool in ImageJ. To determine the level of phosphorylation, band intensity for pAKT1/2/3 
was normalized against total AKT1/2/3, and pERK1/2 normalized against total ERK1/2. 
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Between probes, antibodies from the previous probe were stripped from the membrane by 
incubating in a stripping solution (62.5 mM Tris HCl, 2% SDS, 0.5% β-mercaptoethanol) for 30 
minutes at 60°C. Primary antibodies were rabbit polyclonal for AKT1/2/3 (Santa Cruz 
Biotechnology, Dallas, TX; sc-8312), pAKT1/2/3 (sc-7985), ERK1 (sc-94), and ERK2 (sc-154); 
and goat polyclonal for pERK1/2 (sc-7976). HRP-conjugated goat anti-rabbit and HRP-
conjugated donkey anti-goat were used as secondary antibodies (Santa Cruz Biotechnology). 
Primary antibody concentrations were 0.8 µg/mL, and secondary antibody concentrations were 
0.2 µg/mL.  
 Statistical Analysis 
Data were analyzed using the mixed procedure of SAS with the fixed effects of siRNA 
treatment, Zn treatment, and their interaction. Results are reported as LS means with SEM. 
Where main effects were significant, differences among means were investigated by adjusting 
for multiple comparisons using Tukey’s honestly significant difference method. Significance was 
set at P < 0.05 and tendencies at P < 0.10. 
 
 Results 
Preliminary tests showed GPR39 mRNA to be present in MAC-T cells, as well as a 
variety of bovine tissues including skeletal muscle, adipose, and milk cells (Table 3.3). In an 
attempt to explore the role of GPR39 in extracellular Zn signaling of bovine MEC’s, MAC-T 
cells were transfected with one of two anti-GPR39 siRNA constructs (siGPR39a or siGPR39b), 
or a universal negative siRNA construct (siCON), and subsequently treated with 100 µM Zn or 0 
µM Zn, harvested, and analyzed for ERK and AKT phosphorylation. Abundance of GPR39 
mRNA was significantly impacted by siRNA treatment (P < 0.01) and level of Zn (P = 0.01; 
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Figure 3.1). There was no significant interaction between siRNA treatment and Zn level. At the 
high Zn level, siGPR39a treatment reduced GPR39 by 63% (P = 0.02), while siGPR39b reduced 
it by 57% (P = 0.04) compared to the control. At the low Zn level, no difference in GPR39 
mRNA was detected between siRNA treatments and control; however, abundance for both 
siRNA treatments was numerically lower than the control. Also, the low-zinc control tended to 
have lower GPR39 abundance compared to the high-zinc control (P = 0.096). 
There was no significant effect of siRNA, Zn, or their interaction on ERK 
phosphorylation (Figure 3.2). There was a tendency for siRNA treatment to affect AKT 
phosphorylation (P = 0.094, Figure 3.3), but Zn and the interaction of siRNA and Zn had no 
effect. 
 
 Discussion 
Analysis by qPCR confirmed the presence of GPR39 mRNA in MAC-T cells. 
Interestingly, the relative abundance of GPR39 mRNA increased with Zn treatment. Cohen et al. 
(2014) found that Caco-2 colonocytes increased expression of GPR39 when differentiating. It is 
possible that Zn treatment caused the cells in this study to start differentiating as well, possibly 
by supplying a limiting nutrient, stimulating increased GPR39 expression. 
Zinc treatment (100 µM) had no distinguishable effect on phosphorylation of ERK or 
AKT, key intermediates of the MAPk and PI3K pathways. Zinc concentration in cow’s milk is 
approximately 60 µM, and plasma normally ranges from 12 – 24 µM (Miller, 1969, 1970). The 
concentration of zinc in our growth medium was 5.98 µM, originating entirely from the 10% 
fetal bovine serum. Our zinc treatment was 100 µM. In previous studies, extracellular Zn 
treatment of 100 µM was effective in eliciting kinase phosphorylation, calcium release, and/or 
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elevated cellular proliferation in a variety of cell types including mouse brain cells, HT29 and 
Caco-2 colonocytes, human salivary gland cells, and keratinocytes (Hershfinkel et al., 2001; 
Cohen et al., 2014, 2012; Besser et al., 2009). Given the lack of response in phosphorylation of 
key intermediates of these pathways, it is not likely that extracellular Zn levels regulate MAPk or 
PI3K pathways in MAC-T cells. However, these results do not preclude the possibility of 
receptor-mediated Zn signaling in bovine mammary epithelia. Many other Zn responses have 
been described in other cell types. The most complete characterization is in colonocytes, where 
extracellular Zn stimulates a variety of GPR39-dependent responses, such as MAPk/PI3K 
activation; regulation of the anti-apoptotic gene, clusterin; regulation of sodium/hydrogen 
exchange; intracellular Ca++ release; and increased proliferation rates (Cohen et al., 2014, 2012; 
Hershfinkel et al., 2001). Here, we have investigated only MAPk/PI3K signaling. Other 
responses are also possible. 
 
 Conclusion 
Given its expression in MAC-T cells, GPR39 may play a role in regulation of bovine 
mammary epithelial cells. This role could possibly be affected by extracellular Zn concentration, 
given the response in GPR39 mRNA abundance to extracellular Zn treatment. Extracellular Zn 
and GPR39 did not impact phosphorylation of ERK or AKT, key intermediates of the MAPk and 
PI3K signaling pathways. Further research is necessary to elucidate the function of this receptor 
in the bovine mammary gland. 
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Table 3.1 Description of siRNA constructs designed for GPR39 knockdown 
Construct1 
Sense strand 
Antisense strand 
Knockdown 
Efficiency 
siGPR39a 
CCGACATCCTGGTCTTCCT 
AGGAAGACCAGGATGTCGG 
63% 
siGPR39b 
CCATGGAGTTCTACAGCAT 
ATGCTGTAGAACTCCATGG 
57% 
1 Both constructs designed to target bovine GPR39, accession number: NM_001143744 
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Table 3.2 Primers used for RT-qPCR 
Gene 
Accession 
number 
Forward primer 
Reverse primer 
Region 
amplified 
Reaction 
Efficiency 
Mean 
CT 
GPR39 NM_001143744 
TGAGAAGGTCTTTGGACCCG 
CAATGACCTGGGAGCAGTCC 
94 – 183 105% 27.26 
RPS9 DT860044.1 
GAACAAACGTGAGGTCTGGAGG 
ATTACCTTCGAACAGACGCCG 
233 – 344 87% 18.17 
RPS15 NM_001024541.2 
GGCGGAAGTGGAACAGAAGA 
GTAGCTGGTCGAGGTCTACG 
23 – 96 92% 15.50 
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Table 3.3 Average CT values for GPR39 and control genes, β-actin and RPS15, in MAC-T 
cells and various bovine tissues 
 Gene 
Tissue GPR39 β-actin RPS15 
Adipose 22.3 17.2 24.5 
MAC-T 28.2 17.7 18.2 
Milk somatic cells 26.3 20.2 23.6 
Skeletal muscle 31.2 22.3 22.1 
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Figure 3.1 GPR39 mRNA abundance is reduced by siRNA constructs, siGPR39a and 
siGPR39b, at the 100 µM Zn level.  
1,2Control cells receiving the 0 µM Zn treatment tended to have lesser abundance of GPR39 than 
those receiving the 100 µM Zn treatment (P < 0.1). a,bWithin the 100 µM Zn series, both siRNA 
treatments significantly reduced GPR39 abundance (P < 0.05). 3Normalized Transcript 
Abundance (NTA) = 2 ^ [(CTsample,reference – CTsample,target) – (CTcontrol,reference – CTcontrol,target)] where 
CT ≡ average cycles of PCR required for absorbance of a well to pass a specified threshold, 
sample ≡ a given treatment combination, control ≡ a mixed combination of all samples in equal 
proportions, reference ≡ the geometric mean of CT values for reference genes RPS9 and RPS15, 
target ≡ GPR39. Values are reported as a proportion of the highest treatment combination: 
siCON, 100Zn. 
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Figure 3.2 Phosphorylation of ERK was unaffected by Zn treatment or silencing of GPR39. 
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Figure 3.3 Phosphorylation of AKT was unaffected by Zn treatment, and tended to be 
affected by GPR39 silencing (P = 0.094). 
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